MODERATE TO SEVERE GLABELLAR LINES
Clinical trials for MODERATE TO SEVERE GLABELLAR LINES explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE GLABELLAR LINES trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE GLABELLAR LINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot wrinkle treatment enters final testing phase
Symptom relief Recruiting nowThis study is testing a single injection called IPN10200 to see if it safely improves the appearance of moderate to severe frown lines between the eyebrows. About 300 adults will receive either the real injection or a placebo (a dummy treatment with no active drug). Researchers w…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
New Wrinkle-Smoothing injection enters final testing phase
Symptom relief Recruiting nowThis study is testing a new injectable treatment called Eveotox for smoothing moderate to severe frown lines between the eyebrows. It will compare a single treatment of Eveotox to a single treatment of Botox and a placebo injection. Later, the study will also test the effects of …
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: JHM BioPharma (Tonghua) Co. , Ltd. • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Could a single shot smooth your frown lines for months?
Symptom relief Recruiting nowThis study is testing a new injectable treatment called IPN10200 for reducing moderate to severe frown lines between the eyebrows. It will involve about 1300 adults to see if a single treatment is effective and safe compared to a placebo, and to learn how well and safely repeat t…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Mar 27, 2026 12:37 UTC